REPLIMUNE GROUP, INC. Operating Lease Cost
REPLIMUNE GROUP, INC. (REPL) reported Operating Lease Cost of $289.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-14
- REPLIMUNE GROUP, INC. operating lease, cost for the quarter ending 2026-06-30 was $289.00K, a 0.35% increase year-over-year.
- REPLIMUNE GROUP, INC. operating lease, cost for the quarter ending 2026-03-31 was $290.00K, a 3.57% increase year-over-year.
- REPLIMUNE GROUP, INC. operating lease, cost for the quarter ending 2025-12-31 was $290.00K, a 2.47% increase year-over-year.
- REPLIMUNE GROUP, INC. operating lease, cost for the quarter ending 2025-09-30 was $290.00K, a 1.75% increase year-over-year.
- REPLIMUNE GROUP, INC. operating lease, cost for fiscal 2026 was $1.16M, a 2.39% increase from fiscal 2025.
- REPLIMUNE GROUP, INC. operating lease, cost for fiscal 2025 was $1.13M, a 0.62% increase from fiscal 2024.
- REPLIMUNE GROUP, INC. operating lease, cost for fiscal 2024 was $1.12M, a 10.22% increase from fiscal 2023.
- REPLIMUNE GROUP, INC. operating lease, cost for fiscal 2023 was $1.02M, a 1.50% increase from fiscal 2022.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $289.00K 10-Q · filed 2026-08-14 | $579.00K derived: sum of 2 quarters · filed 2026-08-14 | $869.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.16M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $290.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $580.00K derived: sum of 2 quarters · filed 2026-06-29 | $870.00K derived: sum of 3 quarters · filed 2026-06-29 | $1.16M 10-K · filed 2026-06-29 |
| 2025-12-31 | $290.00K 10-Q · filed 2026-02-03 | $580.00K derived: sum of 2 quarters · filed 2026-02-03 | $866.00K 10-Q · filed 2026-02-03 | $1.15M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | $290.00K 10-Q · filed 2025-11-06 | $577.00K 10-Q · filed 2025-11-06 | $858.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.14M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $288.00K 10-Q · filed 2026-08-14 | $568.00K derived: sum of 2 quarters · filed 2026-08-14 | $851.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.14M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $563.00K derived: sum of 2 quarters · filed 2026-06-29 | $848.00K derived: sum of 3 quarters · filed 2026-06-29 | $1.13M 10-K · filed 2026-06-29 |
| 2024-12-31 | $283.00K 10-Q · filed 2026-02-03 | $568.00K derived: sum of 2 quarters · filed 2026-02-03 | $849.00K 10-Q · filed 2026-02-03 | $1.13M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $285.00K 10-Q · filed 2025-11-06 | $566.00K 10-Q · filed 2025-11-06 | $848.00K derived: sum of 3 quarters · filed 2025-11-06 | $1.13M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $281.00K 10-Q · filed 2025-08-07 | $563.00K derived: sum of 2 quarters · filed 2025-08-07 | $842.00K derived: sum of 3 quarters · filed 2025-08-07 | $1.12M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | $561.00K derived: sum of 2 quarters · filed 2025-05-22 | $842.00K derived: sum of 3 quarters · filed 2025-05-22 | $1.12M 10-K · filed 2025-05-22 |
| 2023-12-31 | $279.00K 10-Q · filed 2025-02-12 | $560.00K derived: sum of 2 quarters · filed 2025-02-12 | $840.00K 10-Q · filed 2025-02-12 | $1.09M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $281.00K 10-Q · filed 2024-11-12 | $561.00K 10-Q · filed 2024-11-12 | $816.00K derived: sum of 3 quarters · filed 2024-11-12 | $1.07M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $280.00K 10-Q · filed 2024-08-08 | $535.00K derived: sum of 2 quarters · filed 2024-08-08 | $787.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.04M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | $507.00K derived: sum of 2 quarters · filed 2024-05-16 | $759.00K derived: sum of 3 quarters · filed 2024-05-16 | $1.02M 10-K · filed 2024-05-16 |
| 2022-12-31 | $252.00K 10-Q · filed 2024-02-08 | $504.00K derived: sum of 2 quarters · filed 2024-02-08 | $763.00K 10-Q · filed 2024-02-08 | $1.03M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | $252.00K 10-Q · filed 2023-11-07 | $511.00K 10-Q · filed 2023-11-07 | $778.00K derived: sum of 3 quarters · filed 2023-11-07 | $1.03M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $259.00K 10-Q · filed 2023-08-03 | $526.00K derived: sum of 2 quarters · filed 2023-08-03 | $775.00K derived: sum of 3 quarters · filed 2023-08-03 | $1.02M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-18 | $516.00K derived: sum of 2 quarters · filed 2023-05-18 | $761.00K derived: sum of 3 quarters · filed 2023-05-18 | $1.00M 10-K · filed 2023-05-18 |
| 2021-12-31 | $249.00K 10-Q · filed 2023-02-09 | $494.00K derived: sum of 2 quarters · filed 2023-02-09 | $736.00K 10-Q · filed 2023-02-09 | $979.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | $245.00K 10-Q · filed 2022-11-03 | $487.00K 10-Q · filed 2022-11-03 | $730.00K derived: sum of 3 quarters · filed 2022-11-03 | $969.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $242.00K 10-Q · filed 2022-08-04 | $485.00K derived: sum of 2 quarters · filed 2022-08-04 | $724.00K derived: sum of 3 quarters · filed 2022-08-04 | $961.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-19 | $482.00K derived: sum of 2 quarters · filed 2022-05-19 | $719.00K derived: sum of 3 quarters · filed 2022-05-19 | $948.00K 10-K · filed 2022-05-19 |
| 2020-12-31 | $239.00K 10-Q · filed 2022-02-03 | $476.00K derived: sum of 2 quarters · filed 2022-02-03 | $705.00K 10-Q · filed 2022-02-03 | $958.00K derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-09-30 | $237.00K 10-Q · filed 2021-11-04 | $467.00K 10-Q · filed 2021-11-04 | $719.00K derived: sum of 3 quarters · filed 2021-11-04 | $981.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $230.00K 10-Q · filed 2021-08-06 | $482.00K derived: sum of 2 quarters · filed 2021-08-06 | $744.00K derived: sum of 3 quarters · filed 2021-08-06 | $1.12M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-20 | $514.00K derived: sum of 2 quarters · filed 2021-05-20 | $892.00K derived: sum of 3 quarters · filed 2021-05-20 | $885.00K 10-K · filed 2021-05-20 |
| 2019-12-31 | $262.00K 10-Q · filed 2021-02-04 | $640.00K derived: sum of 2 quarters · filed 2021-02-04 | $633.00K 10-Q · filed 2021-02-04 | |
| 2019-09-30 | $378.00K 10-Q · filed 2020-11-05 | $492.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $114.00K 10-Q · filed 2020-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |